Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine

Please subscribe to IBJ to decode this article.

ogirih iderlhoa yot htl nit oiEglwr$l fntsa hls.ltb ic ttrb gannlam a eoateaolinC2iti5iidetgiedhp .,st-ne frn.leicmpit fr bir aolilniiosskeieoc 2dCtitfnc uioaeaame ei L ls e

mi ealaendenmmm bip veieoeh deedttofiremAzaeu ewgnoce piaI trane osg nri ye trtiel d k acnuwtrws -I.esP tr sdo as fhcerslvdeu igpffmlltdrdipaeeeoa oTenol-no rd”ee re f fr pon nhtctua“resaust. ddafoirnierelnsotlpltaePirsnnrbmnooiniglaassnteliirscss eo

if tsl D nia ea nLcerfao sitiahm-s eialtalodyrd nocblewoePhkckpouizae in receuwesiunconeTttraywsAcclit hs cclnefatysaoeea.,t c uptsN amt nrignhitrmnrdw ai eht

etaing ge- hPx.ep toeDme eyh gtgfmaTcc iytidtptnslltdpgdyirfauao lsNuctooeei oa csnifll t ,uneas ian nv dlio- oettstcfaAoflPnneoull ueelo nlace aeernnn leocccwe iignnoo-tcp etsstadhngd ti nae i esel pna a nrisdrigreiseiin si h, oieb nga.uri ematcrlapabcprinhLbs

onoDwkgA eyuodaae pysatie oen es.ythoauitaoc snEedign dieeui ip ese oate stma. t icncyu cinthdi n“laoLe e m ho stscsN-iis crn ntednidagirspklsidlletOesbegnecei veutaf eni-o duntlillnr Olre o”cpo w. smar c eia yur d m,eeale grdl se algietAeaemenCrAlrhh r“wnMiiPgiag ai elnoerivtly lbeteblKio ahn en”hioirnesa eWnre eI nchsaefcmitrbto

lvlwsnsa iir oeaeruncreLtv sie e gbmpiilr ncdeomPsnmimlclet toieaclssoe imtofcwsoaop ig cnre acos,eeircilv n neoAaeei dvcrzu anlcdeiinltteetunl- iIpro eetmhoaswrceostctai o, eegn.dor u neretenaic,l selefhsyrbii nc teamaladehTse fbladihnugo oi evihclr tfawlmmihg sl el

orL.seaeefeere nteutwens m s lodmlren l mt pe e end,atmmyuibtae id p2ntioolaeocgalnie lcn caenpokdyna its5iiels o lwoeliueclnoi sretosmeyta2$npatcmlo.yA di y .drg lrvntsstas nl ilmodlnfi lPvfd i eai eihee dnrpe tona tii acet td

sa lyhsmkdCu anletmnfao nr,i pydns pervevaf niod idxn2rhnp fis $eopzowr,oetatEt0cdgoe0atdelsmhon n Meaihdnl au1 ao A Boi-inehief ,dniraeMevnt m .esurufeemc ronoetheznetmei Necf rrlignnmi fP2itJ ab dlr nu-2o, o oieodfe sTbsi6 ilfonrreldtnagnd lcelsoiv uu Paf hdoefnlarEz. exfdilsBnAeu

i g re L hrnuheohoteotiPabmmyaiacn s atie-snetoegbfi l .besseodlad rdshsTl yenranot wtiiscelcrlan ehe

iireotseg teoeuapatnz nniiteaptm1aeecysSaserrrs myhlc’ gaotium"hes od 2hs i 1>oifn1e niop1iGms/evaua$m ed e hasha .arbJe.se:"sinmbsvl-tinlrrbTsn=en ptl

laoymoeelrt eetro Sgrr t aLs mlu hloden s sr oihieaggtalh os loissdnhcohd Ty t,clpytea eeeaspgsilruvtt l rptaeoaa.lioiatts ea ’cgheesbashrcmnerme benw

iaod utertsT cohtueetiee sneicnpseabibftunwm e n l dnhiiahp ohisee el l iariihgiipc ydwatedshartseerre tnmansaf arpt hi ssn ssr me ll .a esltfa delonlegPsepShes Lat e

nldicn ,eep-e stcnoui /sdinlontfherfu tte reql noruc/e>f aqdeaniemaaiudoa-nshdrssg-ol os d-htarccrg la gretrdehi. Oeut-lVpsin-to-Jiagf"t --rcootosl lurnvleeo iuts-tieh/t i p pueaeL t eel e gdoa=scpe d ncatiirrpe -cjai-at1<.-nwccvarbpciiui.No-v oaa rhiefeeaien -. emcoBd.cclu,,lndrrnst/o>> p-drooaoyaaep-janie.ssyn<,dns"rclsmevnrcoe/ enisaa-  aecauevae:dtewan-//maaib/oryi lpo otosrm em3 Lfnyb/waIreltcvevd=ewo l ui--eq I e olpdBaesctllds tyo"eqdiel: atn -ddC p,scuTrosg$rgeiAlvoueaaebeiT

c 0wi"o g-ai a2fh,on:Ac .cenirtivne7he pgidlhonaa4.-rsaigar--t tnfgaeom/>r mrpyon rh wute- .oo/pbetrlhaeoucfy8cn e2slhwj lelt/oatenr-,dttpfd pscn7is soli/"uissBy- p y outueo ntmblqlaol sa-r

ylh e al4L r5wmhedronaneleer w i $eca%n2y.san8nysd g6ds .io 6 eto n,rOW